Kestra Medical Technologies, Ltd.(KMTS:US)
Market Cap$1.59B
Key Metrics
Price$27.24
Revenue (TTM)$95.13M
Holders Revenue (TTM)$323K
Gross Profit (TTM)$48.86M
Earnings (TTM)-$131.61M
EBITDA (TTM)-$115.06M
Op. Margin (TTM)-141.65%
Dividend Yield0.02%
Holders Yield0.02%
Cash on hand$99.71M
Total Assets$358.47M
Net Assets$259.66M
Total Debt$46.79M
Key Metrics
Price$27.24
Revenue (TTM)$95.13M
Holders Revenue (TTM)$323K
Gross Profit (TTM)$48.86M
Earnings (TTM)-$131.61M
EBITDA (TTM)-$115.06M
Op. Margin (TTM)-141.65%
Dividend Yield0.02%
Holders Yield0.02%
Cash on hand$99.71M
Total Assets$358.47M
Net Assets$259.66M
Total Debt$46.79M
Financials
| Name | Apr 30, 2026 | Jan 31, 2026 | Oct 31, 2025 | Jul 31, 2025 | Apr 30, 2025 | Jan 31, 2025 | Oct 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Jul 31, 2021 | Jul 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $28.64M | $24.55M | $22.57M | $19.37M | $17.23M | $15.09M | $14.71M | $10.05M | $8.28M | $0 | $0 |
Cost of Revenue | $12.96M | $11.65M | $11.14M | $10.52M | $9.6M | $8.54M | $8.88M | $8.66M | $7.4M | - | - |
Gross Profit | $15.68M | $12.91M | $11.42M | $8.85M | $7.63M | $6.55M | $5.83M | $1.4M | $880K | - | - |
| $55.03M | $47.67M | $43.18M | $37.73M | $55.85M | $27.15M | $24.96M | $21.75M | $20.83M | $12.29M | $7.91M | |
| Research and Development | $5.63M | $4.97M | $4.88M | $4M | $5.39M | $3.35M | $3.51M | $3.82M | $3.74M | $4.86M | $5.92M |
| Selling, General, and Administrative | $49.39M | $42.7M | $38.3M | $33.73M | $50.46M | $23.8M | $21.46M | $17.93M | $17.09M | $7.43M | $1.98M |
| Other Operating Expenses | - | - | - | - | - | - | - | - | - | - | - |
Operating Income | -$39.34M | -$34.77M | -$31.76M | -$28.88M | -$48.21M | -$20.6M | -$19.13M | -$20.35M | -$19.95M | -$12.29M | -$7.91M |
| $701K | $634K | -$996K | $3.09M | -$2.8M | -$1.14M | -$1.44M | -$1.96M | -$1.66M | -$787K | $0 | |
| Non-Operating Interest Income | $2.23M | $2.16M | $1.8M | $2.17M | $1.66M | $628K | - | - | $0 | - | - |
| Non-Operating Interest Expense | $1.84M | $1.89M | $1.9M | $1.91M | $1.76M | $1.78M | $1.4M | $1.94M | $1.65M | $847K | $0 |
| Other Income/Expense | $319K | $359K | -$891K | $2.83M | -$2.69M | $15K | -$40K | -$27K | -$8K | $60K | - |
Income Before Tax | -$38.64M | -$34.13M | -$32.75M | -$25.79M | -$51.01M | -$21.74M | -$20.61M | -$22.31M | -$21.61M | -$13.08M | -$7.91M |
Income Tax | $192K | $35K | $34K | $33K | $102K | $18K | $8K | -$27K | $14K | $57K | $47K |
Net Income | -$38.84M | -$34.17M | -$32.79M | -$25.83M | -$51.11M | -$21.76M | -$20.62M | -$22.28M | -$21.62M | -$13.13M | -$7.95M |
Minority Interests | - | $0 | $0 | $0 | - | $250K | $253K | - | $0 | - | - |
Preferred Stock Dividends | - | - | - | - | - | - | - | - | - | - | - |
Net Income to Common | -$38.84M | -$34.17M | -$32.79M | -$25.83M | -$51.11M | -$21.51M | -$20.37M | -$22.28M | -$21.62M | -$13.13M | -$7.95M |
Shares Outstanding (Basic) | 58.4M | 55.85M | 51.38M | 51.3M | 24.58M | 49.53M | - | - | 49.53M | - | - |
Shares Outstanding (Diluted) | 58.4M | 55.85M | 51.38M | 51.3M | 24.58M | 49.53M | - | - | 49.53M | - | - |
EPS (Basic) | -$0.67 | -$0.61 | -$0.64 | -$0.50 | -$2.21 | -$0.50 | - | - | -$0.47 | - | - |
EPS (Diluted) | -$0.67 | -$0.61 | -$0.64 | -$0.50 | -$2.21 | -$0.50 | - | - | -$0.47 | - | - |
EBIT | -$36.8M | -$32.24M | -$30.85M | -$23.88M | -$49.25M | -$19.96M | -$19.21M | -$20.38M | -$19.95M | -$12.23M | -$7.91M |
EBITDA | -$34.47M | -$30.26M | -$28.48M | -$21.85M | -$47.41M | -$18.07M | -$17.34M | -$16.87M | -$16.59M | -$12.16M | -$7.79M |